PR Newswire: news distribution, targeting and monitoring

Emergent BioSolutions Appoints Allen Shofe Vice President of Government Affairs

Share with Twitter Share with LinkedIn
    GAITHERSBURG, Md., Sept. 15 /PRNewswire/ -- Emergent BioSolutions Inc.
 today announced the appointment of Allen Shofe to the position of Vice
 President of Government Affairs.  In this position, Mr. Shofe will be
 responsible for designing, implementing and overseeing all aspects of the
 company's domestic and international government affairs initiatives.
     "Allen is a versatile and highly astute government relations and public
 affairs executive," said Fuad El-Hibri, CEO of Emergent BioSolutions.  "His
 government affairs expertise and extensive network of professional contacts
 throughout the United States and Europe will prove invaluable as we continue
 our efforts to become a global leader in our field."
     Mr. Shofe has more than 15 years experience in government relations and
 government affairs at the Federal and state levels, as well as in the
 international arena.  Mr. Shofe previously held the position of Director of
 Federal Government Relations at Eli Lilly and Company, where he managed a
 series of government initiatives, including those that focused on intellectual
 property, patent law and tort reform.  Mr. Shofe received his BA in
 International Relations/Diplomacy at the University of Minnesota and an LL.M,
 Master of Laws from the University of Leicester in the United Kingdom.
     "I look forward to the opportunity to help advance Emergent BioSolutions
 into a world class biopharmaceutical company," said Mr. Shofe.  "This company
 has such a promising future, and to be a part of its growth and success is
 something I am extremely proud of."
     About Emergent BioSolutions
     Emergent BioSolutions Inc., formed in 2004, is dedicated to the research,
 development and manufacture of novel products which harness the immune system
 to treat and prevent disease.  These include vaccines and related products for
 prophylactic and therapeutic use against common infectious diseases and
 biological weapons of mass destruction.  The company currently employs more
 than 450 people with facilities in Gaithersburg and Frederick, Maryland,
 Lansing, Michigan, Berkshire, U.K. and Munich Germany.  More information about
 Emergent BioSolutions and its subsidiaries can be found at

SOURCE Emergent BioSolutions Inc.

Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.



PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.


Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.


Online Member Center

Not a Member?
Click Here to Join
Search News Releases
Advanced Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release